DAVID MARTINEZ GARZA: Open Payments
NPI 1851886691 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,369 in 58 payments from 7 companies in 2025. Trend: 2023 $433 · 2024 $781 · 2025 $1,369
Food & beverage: $1,369
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 12 | $283 |
| Indivior Inc. | 10 | $267 |
| Janssen Pharmaceuticals, Inc | 11 | $230 |
| Teva Pharmaceuticals USA, Inc. | 9 | $200 |
| E.R. Squibb & Sons, L.L.C. | 6 | $156 |
| Luye Pharma (USA) Ltd. | 6 | $141 |
| Otsuka America Pharmaceutical, Inc. | 4 | $90 |
Products named: SUBLOCADE, INVEGA SUSTENNA, ARISTADA, COBENFY, ERZOFRI EXTENDED-RELEASE, AUSTEDO XR, UZEDY, ABILIFY ASIMTUFII.
Industry payments across FL — which companies pay providers there.
